Fulgent Genetics, Inc. FLGT Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $50.19M-9.0% | $55.14M-43.4% | $97.47M+22.6% | $79.51M-51.8% | ||
| $285.88M+40.9% | $202.96M— | —— | —— | ||
| $84.76M+22.8% | $69.02M+35.0% | $51.13M-3.1% | $52.75M-62.0% | ||
| $22.55M-2.0% | $23.02M-29.3% | $32.56M-33.4% | $48.89M+117% | ||
| $107.1M+3,030% | $3.42M— | —— | —— | ||
| $550.49M+55.7% | $353.57M-30.4% | $507.85M-19.1% | $627.87M+2.6% | ||
| $112.55M+6.6% | $105.55M+26.5% | $83.46M+2.6% | $81.35M+30.6% | ||
| $25.08M+13.7% | $22.06M0.0% | $22.06M-84.6% | $143.03M+181% | ||
| $64.79M-8.0% | $70.39M-50.8% | $143.05M-5.0% | $150.64M+319% | ||
| $22.86M-31.7% | $33.46M-4.1% | $34.9M-20.9% | $44.12M+314% | ||
| $369.27M-35.3% | $570.35M+34.7% | $423.57M+29.7% | $326.65M-32.7% | ||
| $1.21B-0.5% | $1.22B-1.2% | $1.24B-10.9% | $1.39B+8.4% | ||
| $18.65M+1.6% | $18.36M+19.6% | $15.36M-33.5% | $23.09M+12.7% | ||
| $34.06M+40.3% | $24.28M+14,704% | $164K-96.9% | $5.3M+680% | ||
| $3.64M+62.7% | $2.23M-22.3% | $2.87M-10.2% | $3.2M-78.0% | ||
| $1.46M+1.3% | $1.44M-63.5% | $3.96M-35.5% | $6.13M+233% | ||
| $360K-9.5% | $398K-26.8% | $544K-42.3% | $943K+184% | ||
| $84.97M+16.6% | $72.9M-0.2% | $73.02M-17.1% | $88.11M-16.3% | ||
| $360K-52.5% | $758K-41.9% | $1.3M-52.8% | $2.76M+59.6% | ||
| $5.24M-5.8% | $5.56M-49.9% | $11.1M-25.6% | $14.93M+108% | ||
| $0-100% | $360K-52.6% | $760K-58.2% | $1.82M+30.0% | ||
| $7.62M+9.3% | $6.97M-53.8% | $15.08M-17.3% | $18.24M+168% | ||
| $106.81M+17.6% | $90.81M-11.0% | $102.04M-12.2% | $116.18M+3.0% | ||
| $3K0.0% | $3K0.0% | $3K0.0% | $3K0.0% | ||
| $574.52M+5.8% | $543.13M+8.3% | $501.72M+3.1% | $486.59M-3.1% | ||
| $529.95M-10.2% | $590.47M-6.7% | $633.18M-21.0% | $801M+21.8% | ||
| $7.51M+2,141% | -$368K-131% | $1.21M+106% | -$20.9M-2,654% | ||
| -$5.27M-29.6% | -$4.07M-44.5% | -$2.82M-188% | $3.19M-55.3% | ||
| $1.11B-1.9% | $1.13B-0.3% | $1.14B-10.3% | $1.27B+9.3% | ||
| $1.21B-0.5% | $1.22B-1.2% | $1.24B-10.9% | $1.39B+8.4% | ||
| $285.88M+40.9% | $202.96M— | —— | —— | ||
| $22.55M-2.0% | $23.02M-29.3% | $32.56M-33.4% | $48.89M+117% | ||
| $22.86M-31.7% | $33.46M-4.1% | $34.9M-20.9% | $44.12M+314% | ||
| $68.49M+6.0% | $64.59M— | —— | —— | ||
| $68.49M+6.0% | $64.59M— | —— | —— | ||
| $68.49M+6.0% | $64.59M— | —— | —— | ||
| $68.49M+6.0% | $64.59M— | —— | —— | ||
| $369.27M-35.3% | $570.35M+34.7% | $423.57M+29.7% | $326.65M-32.7% | ||
| $22.86M-31.7% | $33.46M-4.1% | $34.9M-20.9% | $44.12M+314% | ||
| $64.79M-8.0% | $70.39M— | —— | —— | ||
| $22.86M-31.7% | $33.46M-4.1% | $34.9M-20.9% | $44.12M+314% | ||
| $34.06M+40.3% | $24.28M-21.0% | $30.74M+23.0% | $24.98M+41.2% | ||
| $34.06M+40.3% | $24.28M-21.0% | $30.74M+23.0% | $24.98M+41.2% | ||
| $28.15M+1.9% | $27.61M+21.6% | $22.7M+108% | $10.9M-45.0% | ||
| $476K+15.5% | $412K-65.2% | $1.18M-79.0% | $5.64M-8.3% | ||
| $476K+15.5% | $412K-65.2% | $1.18M-79.0% | $5.64M-8.3% | ||
| $5.6M-11.4% | $6.32M-49.1% | $12.41M-29.9% | $17.69M+98.4% | ||
| $7.28M+59.6% | $4.56M-23.7% | $5.98M-39.2% | $9.84M+1,257% | ||
| $574.52M+5.8% | $543.13M+8.3% | $501.72M+3.1% | $486.59M-3.1% | ||
| $3K0.0% | $3K0.0% | $3K0.0% | $3K0.0% | ||
| $6.94M+8.9% | $6.37M-20.0% | $7.96M— | —— | ||
| $360K-9.5% | $398K-26.8% | $544K-42.3% | $943K+184% | ||
| $68.49M+6.0% | $64.59M— | —— | —— | ||
| -$5.27M-29.6% | -$4.07M-44.5% | -$2.82M-188% | $3.19M-55.3% | ||
| $7.28M+59.6% | $4.56M-23.7% | $5.98M-39.2% | $9.84M+1,257% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Fulgent Genetics, Inc.'s total assets?
- Fulgent Genetics, Inc. (FLGT) holds $1.2B in total assets, down 4.1% year over year.
- How much debt does Fulgent Genetics, Inc. have?
- Fulgent Genetics, Inc. carries $8.2M in total debt against $1.0B of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Fulgent Genetics, Inc. have?
- Fulgent Genetics, Inc. holds $23.4M in cash and equivalents.
- Can Fulgent Genetics, Inc. cover its short-term obligations?
- Its current ratio is 5.31 — current assets exceed current liabilities.
- Where does Fulgent Genetics, Inc.'s balance sheet data come from?
- Every line is extracted from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
